|
Burkina Faso
The goal of the National Programme to Eliminate Lymphatic Filariasis (NPELF) is to eliminate LF by 2015.
The World Health Organization (WHO) is the Secretariat of the Global Programme to Eliminate Lymphatic Filariasis and provides technical and financial support. Detailed information (endemicity, MDA, monitoring and evaluation) on this and other NPLEF can be found on www.who.int/lymphatic_filariasis
Implementation of the NPELF
 |
MDA
Therapeutic
coverage
Click graph for full size version |
Année
du TDM |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
Nombre de personnes
traitées |
431 399 |
1 801 125 |
5 065 181 |
6 239 697 |
10 493 203 |
11 152 923 |
Couverture Thérapeutique |
77,23% |
68,94% |
71,60 % |
74,27% |
77,21% |
80,00% |
Country data
Population |
Circa 13.5 million |
Endemicity |
All 55 districts are endemic |
Clinical manifestations |
It is estimated that 120,000 are affected |
Drug regime |
Albendazole – donated by GlaxoSmithKline
Mectizan® - donated by Merck & Co. Inc. |
MDA implementation cycle |
December/January annually |
Treatment strategy |
Door-to-door and some kiosks |
Social mobilisation |
Awareness is planned according to local characteristics and backed up, wherever possible, by local political, religious and community leaders |
Vector control |
Social mobilization by reinforcing Malaria bednet use with messages for LF and Malaria prevention |
Co-implementation |
Onchocerciasis, schistosomiasis, soil-transmitted helminths, trachoma and malaria – where appropriate |
Recognition
Filaria species |
|
|
|
|
|
|
|
|
|
Wuchereria bancrofti |
|
Onchocerca volvulus |
|
Loa loa |
|
Mansonella perstans |
|
Vectors |
|
|
|
|
|
|
|
|
|
Anopheles gambiae complex |
|
An. funestus |
|
|
|
|
|
Diagnostics |
|
|
|
|
|
|
|
|
|
ICT |
|
Blood slide |
|
|
|
|
|
Training conducted
Year |
Type of training |
Number trained |
2000 |
|
|
2001 |
LF management (Agents de santé) |
98 |
Drug distributors |
2172 |
Disability alleviation |
0 |
2002 |
LF management (Agents de santé) |
504 |
Drug distributors |
5296 |
Disability alleviation |
301 |
2003 |
LF management (Agents de santé) |
1321 |
Drug distributors |
11602 |
Disability alleviation |
390 |
2004 |
LF management (Agents de santé) |
1308 |
Drug distributors |
12645 |
Disability alleviation |
433 |
2005 |
LF management (Agents de santé) |
2845 |
Drug distributors |
23592 |
Disability alleviation |
121 |
2006 |
LF management (Agents de santé) |
2984 |
Drug distributors |
32192 |
Disability alleviation |
70 |
Programme Support & Partnerships
The NPELF is included in both the national and district (IU) level budgets
Partners |
Activities |
Mapping |
MDA |
Social Mobilisation |
Morbidity Management |
Hydrocoele surgery |
Operational Research |
Training |
M&E
Surveillance |
Funding partners |
Helen Keller International |
|
|
|
|
|
|
|
|
|
Handicap International |
|
|
|
|
|
|
|
|
|
Health & Development International |
|
|
|
|
|
|
|
|
|
FDC* |
|
|
|
|
|
|
|
|
|
Liverpool LFSC |
|
|
|
|
|
|
|
|
|
Emory LFSC |
|
|
|
|
|
|
|
|
|
GAELF |
|
|
|
|
|
|
|
|
|
Rotary international |
|
|
|
|
|
|
|
|
|
* Fondation pour le Développement Communautaire
Disability prevention programme
The case management is being implemented in two regions (Central-East and Southwest) by Handicap International.
In other regions, case management of hydrocoeles and lymphoedema is provided by health workers as part of their routine work.
Budget line
In the MOH annual budget, title: “Programme national d’eradication de la filariose lymphatique”
|
|
